Literature DB >> 24801644

Continuous subcutaneous insulin infusion in preschool children: butt or tummy, which is the best infusion set site?

Angela Zanfardino1, Dario Iafusco, Alessia Piscopo, Alessandra Cocca, Pasquale Villano, Santino Confetto, Elisabetta Caredda, Stefania Picariello, Loredana Russo, Francesca Casaburo, Assunta S Rollato, Emilia Forgione, Gianvincenzo Zuccotti, Francesco Prisco, Andrea E Scaramuzza.   

Abstract

BACKGROUND: Choosing the right infusion set site can be an important factor in obtaining good glycemic control, especially in very young children. In an attempt to identify the best infusion site, we performed a crossover study in six preschool children with type 1 diabetes using insulin pump therapy. SUBJECTS AND METHODS: We enrolled six patients 5.2±0.7 years old (range, 4-6 years), with type 1 diabetes for more than 1.5 years, using insulin pump therapy for at least 6 months. For each patient, body mass index, glycated hemoglobin, and all data downloaded from the system were evaluated on two occasions: the first with the infusion set placed on the buttock and the second on the abdomen, each for 3 days. The order of infusion set placement was randomized. Mean capillary blood glucose, mean continuous glycemia, mean area under the curve (AUC) using the trapezoidal rule for both >140 mg/dL and <70 mg/dL, insulin daily dose, carbohydrate/insulin ratio, total basal insulin, total bolus insulin, and mean amplitude of glucose excursions (MAGE) were evaluated.
RESULTS: Mean glycemic values, mean AUC >140 mg/dL, and MAGE were significantly lower when the infusion set was placed on the buttock versus the abdomen (144.6±31.9 mg/dL vs. 166.0±34.8 mg/dL [P=0.000], 28.4±18.3% vs. 48.8±28.2% [P=0.000], and 32±10 vs. 60±15 mg/dL [P<0.001], respectively), whereas mean AUC <70 mg/dL was higher (1.47±2.77% vs. 0.87±1.03% [P<0.001]).
CONCLUSIONS: The present findings suggest that preschool children with type 1 diabetes using insulin pump therapy could benefit from inserting the infusion set in the buttock instead of the abdomen.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24801644     DOI: 10.1089/dia.2013.0357

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  5 in total

1.  Tissue Response to Subcutaneous Infusion Catheter.

Authors:  Ershuai Zhang; Zhiqiang Cao
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

2.  Artificial Pancreas in Young Children.

Authors:  Rebecca A Ohman-Hanson; Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

3.  Sensor Augmented Pump Therapy is Safe and Effective in Very Low Birth Weight Newborns Affected by Neonatal Diabetes Mellitus, With Poor Subcutaneous Tissue: Replacement of the Insulin Pump Infusion Set on the Arm, a Video Case Report.

Authors:  Angela Zanfardino; Mauro Carpentieri; Alessia Piscopo; Stefano Curto; Emanuele Miraglia Del Giudice; Alessia Inverardi; Mario Diplomatico; Sabino Moschella; Ferdinando Spagnuolo; Elisabetta Caredda; Paolo Montaldo; Dario Iafusco
Journal:  J Diabetes Sci Technol       Date:  2021-09-02

4.  Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.

Authors:  Carolina Spinelli Alvarenga; Rebecca Ortiz La Banca; Rhyquelle Rhibna Neris; Valéria de Cássia Sparapani; Miguel Fuentealba-Torres; Denisse Cartagena-Ramos; Camila Lima Leal; Marcos Venicio Esper; Lucila Castanheira Nascimento
Journal:  BMC Endocr Disord       Date:  2022-02-19       Impact factor: 2.763

Review 5.  Metabolic Treatment of Wolfram Syndrome.

Authors:  Dario Iafusco; Angela Zanfardino; Alessia Piscopo; Stefano Curto; Alda Troncone; Antonietta Chianese; Assunta Serena Rollato; Veronica Testa; Fernanda Iafusco; Giovanna Maione; Alessandro Pennarella; Lucia Boccabella; Gulsum Ozen; Pier Luigi Palma; Cristina Mazzaccara; Nadia Tinto; Emanuele Miraglia Del Giudice
Journal:  Int J Environ Res Public Health       Date:  2022-02-27       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.